Total Payments
$7,173
2024 Payments
$530.87
Companies
33
Transactions
353
Medicare Patients
2,776
Medicare Billing
$408,680
Payment Breakdown by Category
Food & Beverage$7,160 (99.8%)
Education$13.22 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,160 | 351 | 99.8% |
| Education | $13.22 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,553 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $645.26 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $484.21 | 33 | $0 (2024) |
| PFIZER INC. | $409.99 | 26 | $0 (2024) |
| Amgen Inc. | $335.60 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $324.71 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $275.20 | 20 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $240.54 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $211.30 | 13 | $0 (2019) |
| Medtronic Vascular, Inc. | $202.55 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $530.87 | 23 | Janssen Pharmaceuticals, Inc ($108.58) |
| 2023 | $448.26 | 23 | PFIZER INC. ($119.95) |
| 2022 | $278.24 | 15 | AstraZeneca Pharmaceuticals LP ($41.82) |
| 2021 | $721.51 | 21 | Abbott Laboratories ($567.64) |
| 2020 | $380.02 | 15 | Abbott Laboratories ($349.90) |
| 2019 | $971.34 | 57 | E.R. Squibb & Sons, L.L.C. ($150.37) |
| 2018 | $1,765 | 88 | Abbott Laboratories ($766.28) |
| 2017 | $2,078 | 111 | Abbott Laboratories ($661.92) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Cardiovascular | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/17/2024 | Nuwellis, Inc. | Aquadex Smartflow Console (Device) | Food and Beverage | Cash or cash equivalent | $77.62 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology | ||||||
| 12/14/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,208 | 1,628 | $513,250 | $178,618 |
| 2022 | 12 | 1,134 | 1,668 | $529,148 | $175,895 |
| 2021 | 9 | 362 | 457 | $145,978 | $49,596 |
| 2020 | 3 | 72 | 75 | $19,935 | $4,572 |
Total Patients
2,776
Total Services
3,828
Medicare Billing
$408,680
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 421 | $77,043 | $35,229 | 45.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 291 | 296 | $111,000 | $34,654 | 31.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 111 | 111 | $121,545 | $31,917 | 26.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 110 | 113 | $50,140 | $25,591 | 51.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 26 | 26 | $26,624 | $14,494 | 54.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 84 | 336 | $30,240 | $14,472 | 47.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $18,760 | $6,837 | 36.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 112 | 112 | $42,000 | $4,895 | 11.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 29 | 29 | $17,632 | $3,817 | 21.6% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 15 | 15 | $6,750 | $2,526 | 37.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 11 | 12 | $4,512 | $1,979 | 43.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 27 | 27 | $2,990 | $1,379 | 46.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 25 | 25 | $1,050 | $467.25 | 44.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 38 | $2,964 | $360.50 | 12.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 126 | 126 | $105,075 | $39,754 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 243 | 331 | $60,573 | $28,008 | 46.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 190 | 192 | $132,456 | $25,666 | 19.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 125 | 159 | $42,780 | $20,893 | 48.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 102 | 408 | $36,720 | $19,782 | 53.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 27 | 27 | $27,648 | $16,613 | 60.1% |
| A9505 | Thallium tl-201 thallous chloride, diagnostic, per millicurie | Office | 2022 | 63 | 165 | $60,009 | $11,072 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $14,280 | $6,007 | 42.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 128 | 128 | $41,120 | $5,851 | 14.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 11 | 11 | $3,889 | $1,311 | 33.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 44 | 46 | $3,590 | $471.49 | 13.1% |
About Dr. Jack Brand, MD
Dr. Jack Brand, MD is a Cardiovascular Disease healthcare provider based in Biloxi, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689678674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Brand, MD has received a total of $7,173 in payments from pharmaceutical and medical device companies, with $530.87 received in 2024. These payments were reported across 353 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,160).
As a Medicare-enrolled provider, Brand has provided services to 2,776 Medicare beneficiaries, totaling 3,828 services with total Medicare billing of $408,680. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Biloxi, MS
- Active Since 06/08/2005
- Last Updated 07/19/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1689678674
Products in Payments
- Merlin Connectivity and Remote (Device) $774.27
- ELIQUIS (Drug) $724.58
- XARELTO (Drug) $645.26
- Quadra Assura CRT Defibrillator (Device) $526.30
- CRT-Ds (Device) $366.10
- LifeVest (Device) $240.54
- ENTRESTO (Drug) $230.79
- PRALUENT (Drug) $211.30
- PRALUENT ALIROCUMAB INJECTION (Biological) $190.55
- Corlanor (Drug) $186.61
- Confirm Rx (Device) $174.08
- Assurity Pacemaker (Device) $172.74
- Repatha (Biological) $148.99
- VERQUVO (Drug) $134.54
- MRI Ready Leads (Device) $128.62
- Supera peripheral stent system (Device) $108.23
- Vascepa (Drug) $106.61
- SAMSCA (Drug) $94.64
- LEQVIO (Drug) $93.92
- PRALUENT (Biological) $84.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Biloxi
Antoine Rizk, M.d, M.D
Cardiovascular Disease — Payments: $38,463
Cardiovascular Disease $38,463
Paul Mullen, M.d, M.D
Cardiovascular Disease — Payments: $36,368
Cardiovascular Disease $36,368
Eva Magiros, M.d, M.D
Cardiovascular Disease — Payments: $3,535
Cardiovascular Disease $3,535
Dr. Gilberto Patino, Md, MD
Cardiovascular Disease — Payments: $2,210
Cardiovascular Disease $2,210
Dr. Alexander Yuan, D.o, D.O
Cardiovascular Disease — Payments: $202.90
Cardiovascular Disease $202.90